Combination of thalidomide with pentoxifylline, ciprofloxacin, and dexamethasone (PCD) in patients with myelodysplastic syndromes (MDS).

被引：0
|
作者：
Raza, A [1 ]
Lisak, L [1 ]
Dutt, D [1 ]
Dean, L [1 ]
Fantroy, L [1 ]
Syed, E [1 ]
Gezer, S [1 ]
Hsu, WT [1 ]
Goldberg, C [1 ]
Loew, J [1 ]
Venugopal, P [1 ]
机构：
[1] Rush Univ, MDS Ctr, Chicago, IL 60612 USA
来源：
BLOOD | 2001年 / 98卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4830
引用
收藏
页码：273B / 273B
页数：1
相关论文
共 50 条
  • [31] The hematologic response to anti-apoptotic cytokine therapy: Results of pentoxifylline, ciprofloxacin, and dexamethasone treatment for patients with myelodysplastic syndrome
    Kim, MK
    Lee, JL
    Cho, HS
    Bae, SH
    Ryoo, HM
    Lee, KH
    Hyun, MS
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2006, 21 (01) : 40 - 45
  • [32] CYTOGENETIC STUDIES IN 69 PATIENTS WITH MYELODYSPLASTIC SYNDROMES (MDS)
    WEH, HJ
    CALAVREZOS, A
    SEEGER, D
    KUSE, R
    HOSSFELD, DK
    EUROPEAN JOURNAL OF HAEMATOLOGY, 1987, 38 (02) : 166 - 172
  • [33] Serum cytokine levels in patients with myelodysplastic syndromes (MDS).
    Allampallam, K
    Shetty, V
    Mundle, S
    Dutt, D
    Reddy, PL
    Alvi, S
    Galili, N
    Saberwal, GS
    Anthwal, S
    Shaikh, MW
    York, A
    Gezer, S
    Venugopal, P
    Raza, A
    BLOOD, 2001, 98 (11) : 269B - 270B
  • [34] CHROMOSOMAL RESULTS IN 50 PATIENTS WITH MYELODYSPLASTIC SYNDROMES (MDS)
    LESSARD, M
    BRIZARD, A
    GUILHOT, F
    TANZER, J
    BLUT, 1988, 56 (06): : C9 - C9
  • [35] Amifostine in combination with cytokines stimulates in vitro hemopoiesis in myelodysplastic syndromes (MDS).
    Rajapaksa, R
    Bhatia, S
    Swarnakar, A
    Kodali, U
    Greenberg, PL
    BLOOD, 1998, 92 (10) : 160B - 160B
  • [36] PENTOXIFYLLINE AND CIPROFLOXACIN IN PATIENTS WITH MYELODYSPLASTIC SYNDROME - A PHASE-II TRIAL
    NEMUNAITIS, J
    ROSENFELD, C
    GETTY, L
    BOEGEL, F
    MEYER, W
    JENNINGS, LW
    ZEIGLER, Z
    SHADDUCK, R
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1995, 18 (03): : 189 - 193
  • [37] N998B: Multicenter phase II trial of thalidomide (Thal) in adult patients with myelodysplastic syndromes (MDS).
    Moreno-Aspitia, A
    Geyer, S
    Li, CY
    Tefferi, A
    Witzig, T
    Niedrinhaus, RD
    Vukov, AM
    Morton, R
    Fitch, T
    Addo, FE
    Dakhil, SR
    Tschetter, L
    Colon-Otero, G
    BLOOD, 2002, 100 (11) : 96A - 96A
  • [38] Cyclosporin A and thalidomide in patients with myelodysplastic syndromes: Results of a pilot study
    Xiao, Zhijian
    Xu, Zefeng
    Zhang, Yue
    Qin, Tiejun
    Zhang, Hongli
    Fang, Liwei
    LEUKEMIA RESEARCH, 2011, 35 (01) : 61 - 65
  • [39] Cyclosporine a without or with thalidomide for the treatment of patients with Myelodysplastic syndromes.
    Xiao, Zhijian
    Xu, Zefeng
    Wang, Jianxiang
    Hao, Yushu
    BLOOD, 2007, 110 (11) : 222B - 222B
  • [40] A Phase II Study Of The Combination Of Azacitidine and Lenalidomide In Patients (pts) With Higher Risk Myelodysplastic Syndromes (MDS)
    Garcia-Manero, Guillermo
    Kadia, Tapan M.
    Daver, Naval
    Jabbour, Elias
    Jain, Nitin
    Cortes, Jorge E.
    Estrov, Zeev
    Borthakur, Gautam
    Dong, Xiao Q.
    Kumar, Veeral J.
    Kantarjian, Hagop M.
    BLOOD, 2013, 122 (21)
12345